Cemdisiran Regeneron-licensed investigational C5 therapy under review for generalized myasthenia gravis, with Phase 3 programs including pozelimab combinations for PNH and geographic atrophy.
Visit productCosigns Received
Be the first Cosign
Put your name behind Cemdisiran.
Add it to your Products I use list and share why you use it.